Clinical performance, efficacy, and safety of the DigniCap system, a scalp-hypothermia system, in preventing chemotherapy (CTX)-induced alopecia in patients (pts) with early-stage breast cancer (BC).

Authors

null

A. Glencer

University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

A. Glencer , M. E. Melisko , L. Esserman , S. A. Melin , H. S. Rugo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session

Track

Special Sessions,Clinical Trials

Sub Track

Supportive Care

Citation

J Clin Oncol 29: 2011 (suppl; abstr TPS244)

Abstract #

TPS244

Poster Bd #

54B

Abstract Disclosures

Similar Posters

Poster

2017 ASCO Annual Meeting

Scalp Cooling Alopecia Prevention trial (SCALP) for patients with early stage breast cancer.

Scalp Cooling Alopecia Prevention trial (SCALP) for patients with early stage breast cancer.

First Author: Julie R. Nangia

Poster

2022 ASCO Quality Care Symposium

Investigating keratinocyte growth factor hair serum for the prevention of chemotherapy-induced alopecia.

Investigating keratinocyte growth factor hair serum for the prevention of chemotherapy-induced alopecia.

First Author: Preethika Potluri

First Author: Christine Brunner